Biointron is pleased to announce our participation in the World Bispecific & TCE Korea 2026. The event will take place in Seoul, South Korea, happening this June 9 – 11, 2026.
The World Bispecific & TCE Korea conference brings together researchers, biopharma leaders, and technology innovators focused on the development of bispecific antibodies and T cell engagers (TCEs). The meeting covers key topics such as next-generation antibody engineering, novel target discovery, clinical development strategies, and manufacturing challenges associated with complex biologics. With increasing momentum in immune redirection and multispecific formats, the conference serves as a platform to exchange insights on advancing these therapies from early research to clinical application.
Biointron looks forward to connecting with partners and industry peers in Seoul and contributing to discussions shaping the future of bispecific and T cell engager therapeutics.
For more details about the event, please visit the World Bispecific & TCE Summit Korea 2026 website [https://worldbispecifics-tce-kr.com/]
Time: June 9 - 11, 2026
Location: COEX Magok Lewest | Seoul, South Korea
Booth: TBD
Biointron is pleased to announce our participation in the Society for Immunother……
Biointron is pleased to announce our participation in The 5th Annual Meeting of ……
Biointron is pleased to announce our participation in The 55th Annual Meeting of……
Biointron is pleased to announce our participation in BIOPLUS-INTERPHEX KOREA 20……
ScientistとScience Exchangeとのご利用可能です。